The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Global cancer statistics
Open accessAbstract
The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer-causing behaviors, particularly smoking, in economically developing countries. Based on the GLOBOCAN 2008 estimates, about 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 64% of the deaths occurred in the economically developing world. Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females, accounting for 23% of the total cancer cases and 14% of the cancer deaths. Lung cancer is the leading cancer site in males, comprising 17% of the total new cancer cases and 23% of the total cancer deaths. Breast cancer is now also the leading cause of cancer death among females in economically developing countries, a shift from the previous decade during which the most common cause of cancer death was cervical cancer. Further, the mortality burden for lung cancer among females in developing countries is as high as the burden for cervical cancer, with each accounting for 11% of the total female cancer deaths. Although overall cancer incidence rates in the developing world are half those seen in the developed world in both sexes, the overall cancer mortality rates are generally similar. Cancer survival tends to be poorer in developing countries, most likely because of a combination of a late stage at diagnosis and limited access to timely and standard treatment. A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination (for liver and cervical cancers), and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake. Clinicians, public health professionals, and policy makers can play an active role in accelerating the application of such interventions globally.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
HPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278
Cited by
Items 201–300 of 423
Sjøblom, B., Grønberg, B. H., Wentzel-Larsen, T., Baracos, V. E., Hjermstad, M. J., Aass, N., Bremnes, R. M., Fløtten, Ø., Bye, A., & Jordhøy, M. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.03.010 · Cited by 143
MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL
Baraniskin, A., Birkenkamp-Demtroder, K., Maghnouj, A., Zöllner, H., Munding, J., Klein-Scory, S., Reinacher-Schick, A., Schwarte-Waldhoff, I., Schmiegel, W., & Hahn, S. A. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs020 · Cited by 142
Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies
Adamu, M. A., Weck, M. N., Gao, L., & Brenner, H. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9482-0 · Cited by 140
Gérard, C., & Brown, K. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.014 · Cited by 136
The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
Zeng, S. S., Yamashita, T., Kondo, M., Nio, K., Hayashi, T., Hara, Y., Nomura, Y., Yoshida, M., Hayashi, T., Oishi, N., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.024 · Cited by 140
Czerninski, R., Amornphimoltham, P., Patel, V., Molinolo, A. A., & Gutkind, J. S. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0147 · Cited by 140
Hong, F., Xu, P., & Zhai, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082189 · Cited by 139
BRAF Mutation in Colorectal Cancer: An Update: Supplementary Issue: Biomarkers for Colon Cancer
Barras, D. (2015) · Biomarkers in Cancer · doi:10.4137/bic.s25248 · Cited by 138
Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform
Lanz, H. L., Saleh, A., Kramer, B., Cairns, J., Ng, C. P., Yu, J., Trietsch, S. J., Hankemeier, T., Joore, J., Vulto, P., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3709-3 · Cited by 135
Wu, C. W., Ng, S. C., Dong, Y., Tian, L., Ng, S. S. M., Leung, W. W., Law, W. T., Yau, T. O., Chan, F. K. L., Sung, J. J. Y., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1750 · Cited by 135
Tumor-Derived Adenosine Promotes Macrophage Proliferation in Human Hepatocellular Carcinoma
Wang, J., Wang, Y., Chu, Y., Li, Z., Yu, X., Huang, Z., Xu, J., & Zheng, L. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.10.021 · Cited by 133
Biswal, B. M., Sulaiman, S. A., Ismail, H. C., Zakaria, H., & Musa, K. I. (2013) · Integrative Cancer Therapies · doi:10.1177/1534735412464551 · Cited by 131
Ford, P. J., & Rich, A. M. (2021) · Addiction · doi:10.1111/add.15513 · Cited by 130
Wu, Y., Li, P., Zhang, H., Shi, Y., Wu, H., Zhang, J., Qian, Y., Li, C., & Yang, J. (2013) · International Journal of Cancer · doi:10.1002/ijc.27779 · Cited by 129
Hou, W. K., Law, C. C., Yin, J., & Fu, Y. T. (2010) · Health Psychology · doi:10.1037/a0020809 · Cited by 130
Kim, E.-J., Kumar, R., Sharma, A., Yoon, B., Kim, H. M., Lee, H., Hong, K. S., & Kim, J. S. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.009 · Cited by 129
Aspe, J. R., Diaz Osterman, C. J., Jutzy, J. M. S., Deshields, S., Whang, S., & Wall, N. R. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.23244 · Cited by 126
Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
Peppercorn, J., Blood, E., Winer, E., & Partridge, A. (2007) · Cancer · doi:10.1002/cncr.22528 · Cited by 123
Sforza, V., Martinelli, E., Ciardiello, F., Gambardella, V., Napolitano, S., Martini, G., della Corte, C., Cardone, C., Ferrara, M. L., Reginelli, A., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i28.6345 · Cited by 123
Ramanathan, R. K., Abbruzzese, J., Dragovich, T., Kirkpatrick, L., Guillen, J. M., Baker, A. F., Pestano, L. A., Green, S., & Von Hoff, D. D. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1343-8 · Cited by 122
Zhang, Z.-J., Bi, Y., Li, S., Zhang, Q., Zhao, G., Guo, Y., & Song, Q. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu124 · Cited by 120
Je, Y., Liu, W., & Giovannucci, E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24124 · Cited by 119
HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer
Chang, H. R., Nam, S., Kook, M.-C., Kim, K.-T., Liu, X., Yao, H., Jung, H. R., Lemos, R., Seo, H. H., Park, H. S., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-307918 · Cited by 119
Vishchuk, O. S., Ermakova, S. P., & Zvyagintseva, T. N. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.03.065 · Cited by 117
Michaylira, C. Z., Wong, G. S., Miller, C. G., Gutierrez, C. M., Nakagawa, H., Hammond, R., Klein-Szanto, A. J., Lee, J.-S., Kim, S. B., Herlyn, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0704 · Cited by 117
Hardcastle, S. J., Kane, R., Chivers, P., Hince, D., Dean, A., Higgs, D., & Cohen, P. A. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4230-1 · Cited by 116
Humphris, G., & Ozakinci, G. (2008) · British Journal of Health Psychology · doi:10.1348/135910708x283751 · Cited by 114
Nielsen, D. S. G., Jensen, B. B., Theil, P. K., Nielsen, T. S., Knudsen, K. E. B., & Purup, S. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2017.10.023 · Cited by 115
Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
Deng, J., Wang, L., Chen, H., Hao, J., Ni, J., Chang, L., Duan, W., Graham, P., & Li, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9908 · Cited by 115
Li, Q., Zhang, D., Chen, X., He, L., Li, T., Xu, X., & Li, M. (2015) · Scientific Reports · doi:10.1038/srep16082 · Cited by 114
Deng, X., Li, Z., Li, G., Li, B., Jin, X., & Lyu, G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01607 · Cited by 114
Regina, A., Demeule, M., Tripathy, S., Lord-Dufour, S., Currie, J.-C., Iddir, M., Annabi, B., Castaigne, J.-P., & Lachowicz, J. E. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0399 · Cited by 112
Perumpail, R. B., Wong, R. J., Ahmed, A., & Harrison, S. A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3821-7 · Cited by 111
Symptom Management in Metastatic Breast Cancer
Irvin, W., Muss, H. B., & Mayer, D. K. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0159 · Cited by 112
Tan, C.-S., Cho, B.-C., & Soo, R. A. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.01.003 · Cited by 105
Hypercholesterolemia Induces Angiogenesis and Accelerates Growth of Breast Tumors In Vivo
Pelton, K., Coticchia, C. M., Curatolo, A. S., Schaffner, C. P., Zurakowski, D., Solomon, K. R., & Moses, M. A. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.03.006 · Cited by 109
Yang, Y.-L., Liu, L., Wang, X.-X., Wang, Y., & Wang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094804 · Cited by 108
Turcotte, S., Gros, A., Hogan, K., Tran, E., Hinrichs, C. S., Wunderlich, J. R., Dudley, M. E., & Rosenberg, S. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300538 · Cited by 107
Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
Bakkum-Gamez, J. N., Wentzensen, N., Maurer, M. J., Hawthorne, K. M., Voss, J. S., Kroneman, T. N., Famuyide, A. O., Clayton, A. C., Halling, K. C., Kerr, S. E., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.552 · Cited by 107
Matsuda, A., Yamaoka, K., Tango, T., Matsuda, T., & Nishimoto, H. (2014) · Quality of Life Research · doi:10.1007/s11136-013-0460-3 · Cited by 105
Huang, H.-P., He, M., Wang, H.-Y., & Zhou, M. (2016) · Breast Cancer · doi:10.1007/s12282-015-0604-0 · Cited by 105
Prognostic role of CIP2A expression in serous ovarian cancer
Böckelman, C., Lassus, H., Hemmes, A., Leminen, A., Westermarck, J., Haglund, C., Bützow, R., & Ristimäki, A. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.346 · Cited by 100
A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells
Kaltschmidt, C., Banz-Jansen, C., Benhidjeb, T., Beshay, M., Förster, C., Greiner, J., Hamelmann, E., Jorch, N., Mertzlufft, F., Pfitzenmaier, J., et al. (2019) · Cancers · doi:10.3390/cancers11050655 · Cited by 102
Hayashi, M., Nomoto, S., Hishida, M., Inokawa, Y., Kanda, M., Okamura, Y., Nishikawa, Y., Tanaka, C., Kobayashi, D., Yamada, S., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-108 · Cited by 101
Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer
Lim, S., Yoo, B. K., Kim, H.-S., Gilmore, H. L., Lee, Y., Lee, H.-P., Kim, S.-J., Letterio, J., & Lee, H.-G. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-928 · Cited by 100
Smout, M. J., Sotillo, J., Laha, T., Papatpremsiri, A., Rinaldi, G., Pimenta, R. N., Chan, L. Y., Johnson, M. S., Turnbull, L., Whitchurch, C. B., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005209 · Cited by 94
Ren, J. S., Freedman, N. D., Kamangar, F., Dawsey, S. M., Hollenbeck, A. R., Schatzkin, A., & Abnet, C. C. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.03.025 · Cited by 99
To, K. K. W., Leung, W. W., & Ng, S. S. M. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.09.011 · Cited by 99
Wu, P., Zhou, Q., Zhu, H., Zhuang, Y., & Bao, J. (2020) · BMC Cancer · doi:10.1186/s12885-020-06803-7 · Cited by 97
RetractedHu, T., To, K. K. W., Wang, L., Zhang, L., Lu, L., Shen, J., Chan, R. L. Y., Li, M., Yeung, J. H. K., & Cho, C. H. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.06.013 · Cited by 99
Zordoky, B. N. M., Bark, D., Soltys, C. L., Sung, M. M., & Dyck, J. R. B. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.01.023 · Cited by 98
Safarinejad, M. R., Shafiei, N., & Safarinejad, S. (2013) · Psycho-Oncology · doi:10.1002/pon.3130 · Cited by 98
Lahner, E., Esposito, G., Pilozzi, E., Purchiaroni, F., Corleto, V. D., Di Giulio, E., & Annibale, B. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1010570 · Cited by 97
Bile acids: From digestion to cancers
Baptissart, M., Vega, A., Maqdasy, S., Caira, F., Baron, S., Lobaccaro, J.-M. A., & Volle, D. H. (2013) · Biochimie · doi:10.1016/j.biochi.2012.06.022 · Cited by 97
PET in the management of locally advanced and metastatic NSCLC
Grootjans, W., de Geus-Oei, L.-F., Troost, E. G. C., Visser, E. P., Oyen, W. J. G., & Bussink, J. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.75 · Cited by 97
van den Hurk, D. G. M., Schellekens, M. P. J., Molema, J., Speckens, A. E. M., & van der Drift, M. A. (2015) · Palliative Medicine · doi:10.1177/0269216315572720 · Cited by 95
Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway
Lou, H., Villagran, G., Boland, J. F., Im, K. M., Polo, S., Zhou, W., Odey, U., Juárez-Torres, E., Medina-Martínez, I., Roman-Basaure, E., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1837 · Cited by 88
E2f8 mediates tumor suppression in postnatal liver development
Kent, L. N., Rakijas, J. B., Pandit, S. K., Westendorp, B., Chen, H.-Z., Huntington, J. T., Tang, X., Bae, S., Srivastava, A., Senapati, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85506 · Cited by 95
Anticancer Drugs Targeting the Mitochondrial Electron Transport Chain
Rohlena, J., Dong, L.-F., Ralph, S. J., & Neuzil, J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3990 · Cited by 91
Vitiello, P. P., Cardone, C., Martini, G., Ciardiello, D., Belli, V., Matrone, N., Barra, G., Napolitano, S., Della Corte, C., Turano, M., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1035-0 · Cited by 96
miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2
Xu, K., Liang, X., Shen, K., Cui, D., Zheng, Y., Xu, J., Fan, Z., Qiu, Y., Li, Q., Ni, L., et al. (2012) · Biochemical Journal · doi:10.1042/bj20120386 · Cited by 93
Xu, J., Jin, B., Chu, T., Dong, X., Yang, H., Zhang, Y., Wu, D., Lou, Y., Zhang, X., Wang, H., et al. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.01.018 · Cited by 92
Lee, P., Bazan, J. G., Lavori, P. W., Weerasuriya, D. K., Quon, A., Le, Q.-T., Wakelee, H. A., Graves, E. E., & Loo, B. W. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.05.001 · Cited by 92
Hughes, D. J., Duarte-Salles, T., Hybsier, S., Trichopoulou, A., Stepien, M., Aleksandrova, K., Overvad, K., Tjønneland, A., Olsen, A., Affret, A., et al. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.131672 · Cited by 91
Sento, S., Sasabe, E., & Yamamoto, T. (2016) · PLOS ONE · doi:10.1371/journal.pone.0148454 · Cited by 91
Impact of obesity upon prostate cancer-associated mortality: A meta-analysis of 17 cohort studies
ZHANG, X., ZHOU, G., SUN, B., ZHAO, G., LIU, D., SUN, J., LIU, C., & GUO, H. (2015) · Oncology Letters · doi:10.3892/ol.2014.2841 · Cited by 91
Coffee Consumption and Risk of Colorectal Cancer: A Meta-Analysis of Observational Studies
Li, G., Ma, D., Zhang, Y., Zheng, W., & Wang, P. (2013) · Public Health Nutrition · doi:10.1017/s1368980012002601 · Cited by 91
Mabrok, H. B., Klopfleisch, R., Ghanem, K. Z., Clavel, T., Blaut, M., & Loh, G. (2012) · Carcinogenesis · doi:10.1093/carcin/bgr256 · Cited by 89
Hayashi, T., Desmeules, P., Smith, R. S., Drilon, A., Somwar, R., & Ladanyi, M. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2343 · Cited by 90
Shan, F., Shao, Z., Jiang, S., & Cheng, Z. (2016) · Cancer Medicine · doi:10.1002/cam4.881 · Cited by 88
Song, J., Miermont, A., Lim, C. T., & Kamm, R. D. (2018) · Scientific Reports · doi:10.1038/s41598-018-36381-5 · Cited by 87
Obesity and ovarian cancer risk: A systematic review
Foong, K. W., & Bolton, H. (2017) · Post Reproductive Health · doi:10.1177/2053369117709225 · Cited by 85
He, J., Zhou, M., Chen, X., Yue, D., Yang, L., Qin, G., Zhang, Z., Gao, Q., Wang, D., Zhang, C., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0378-z · Cited by 85
Telomeres, telomerase and colorectal cancer
Bertorelle, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i8.1940 · Cited by 82
Schellekens, M. P. J., Karremans, J. C., van der Drift, M. A., Molema, J., van den Hurk, D. G. M., Prins, J. B., & Speckens, A. E. M. (2017) · Mindfulness · doi:10.1007/s12671-016-0602-0 · Cited by 85
Coffee Consumption and Risk of Colorectal Cancer: A Meta-Analysis of Case-Control Studies
Galeone, C., Turati, F., La Vecchia, C., & Tavani, A. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9623-5 · Cited by 86
Gosain, R., Gage-Bouchard, E., Ambrosone, C., Repasky, E., & Gandhi, S. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00815-y · Cited by 85
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
Hu, J., Tan, P., Ishihara, M., Bayley, N. A., Schokrpur, S., Reynoso, J. G., Zhang, Y., Lim, R. J., Dumitras, C., Yang, L., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01362-2 · Cited by 85
Bertorelle, R., Briarava, M., Rampazzo, E., Biasini, L., Agostini, M., Maretto, I., Lonardi, S., Friso, M. L., Mescoli, C., Zagonel, V, et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.602 · Cited by 77
Role of SALL4 in the progression and metastasis of colorectal cancer
Forghanifard, M. M., Moghbeli, M., Raeisossadati, R., Tavassoli, A., Mallak, A. J., Boroumand-Noughabi, S., & Abbaszadegan, M. R. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-6 · Cited by 82
Karimi Ardestani, S., Tafvizi, F., & Tajabadi Ebrahimi, M. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119851255 · Cited by 82
Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells
Lian, S., Xie, R., Ye, Y., Lu, Y., Cheng, Y., Xie, X., Li, S., & Jia, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-40241-1 · Cited by 81
Hanly, P. A., & Sharp, L. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-224 · Cited by 81
Pinato, D. J., Cortellini, A., Sukumaran, A., Cole, T., Pai, M., Habib, N., Spalding, D., Sodergren, M. H., Martinez, M., Dhillon, T., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08033-x · Cited by 79
Crosstalk between gut microbiota and Sirtuin-3 in colonic inflammation and tumorigenesis
Zhang, Y., Wang, X.-L., Zhou, M., Kang, C., Lang, H.-D., Chen, M.-T., Hui, S.-C., Wang, B., & Mi, M.-T. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-017-0002-0 · Cited by 78
Barriers to Cervical Cancer Screening in Rural Kenya: Perspectives from a Provider Survey
Rosser, J. I., Hamisi, S., Njoroge, B., & Huchko, M. J. (2015) · Journal of Community Health · doi:10.1007/s10900-015-9996-1 · Cited by 79
Blockade of Kv1.3 channels ameliorates radiation-induced brain injury
Peng, Y., Lu, K., Li, Z., Zhao, Y., Wang, Y., Hu, B., Xu, P., Shi, X., Zhou, B., Pennington, M., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not221 · Cited by 78
Volkova, E., Willis, J. A., Wells, J. E., Robinson, B. A., Dachs, G. U., & Currie, M. J. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606005 · Cited by 78
Liang, G., Liu, M., Wang, Q., Shen, Y., Mei, H., Li, D., & Liu, W. (2017) · Oncotarget · doi:10.18632/oncotarget.15324 · Cited by 78
Prevalence of major risk factors and use of screening tests for cancer in the United States
Fedewa, S. A., Sauer, A. G., Siegel, R. L., & Jemal, A. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0134 · Cited by 77
Self-citationWAN, Y., XIN, Y., ZHANG, C., WU, D., DING, D., TANG, L., OWUSU, L., BAI, J., & LI, W. (2014) · Oncology Letters · doi:10.3892/ol.2014.1959 · Cited by 76
High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer
Zhu, J., Ma, J., Wang, X., Ma, T., Zhang, S., Wang, W., Zhou, X., & Shi, J. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.08.003 · Cited by 75
Metformin and prostate cancer mortality: A meta-analysis
Stopsack, K. H., Ziehr, D. R., Rider, J. R., & Giovannucci, E. L. (2016) · Cancer Causes & Control · doi:10.1007/s10552-015-0687-0 · Cited by 72
Spatial Analysis of Breast Cancer Incidence in Iran
Mahdavifar, N., Pakzad, R., Ghoncheh, M., Pakzad, I., Moudi, A., & Salehiniya, H. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.s3.59 · Cited by 63
High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival
Wang, Q., Ni, Q., Wang, X., Zhu, H., Wang, Z., & Huang, J. (2015) · Medical Oncology · doi:10.1007/s12032-014-0372-2 · Cited by 70
Xiao, F., zhang, W., Chen, L., Chen, F., Xie, H., Xing, C., Yu, X., Ding, S., Chen, K., Guo, H., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-195 · Cited by 71
Zheng, J.-S., Yang, J., Fu, Y.-Q., Huang, T., Huang, Y.-J., & Li, D. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.741762 · Cited by 70
Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor β1
LI, G.-C., ZHANG, H.-W., ZHAO, Q.-C., SUN, L., YANG, J.-J., HONG, L., FENG, F., & CAI, L. (2016) · Oncology Letters · doi:10.3892/ol.2015.3997 · Cited by 72
Expressive writing in early breast cancer survivors
Craft, M. A., Davis, G. C., & Paulson, R. M. (2013) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2012.06008.x · Cited by 70
Luo, K., Gao, Y., Yin, S., Yao, Y., Yu, H., Wang, G., & Li, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.07.029 · Cited by 70
Metadata
- Authors
- Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2011-02-04
- Volume
- 61
- Issue
- 2
- Pages
- 69-90
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2106787323
- Cited by
- 54,679
- References
- 3
- FWCI
- 2387.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.